You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Claims for Patent: 11,191,834


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,191,834
Title:Protein formulations and methods of making same
Abstract:The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.
Inventor(s):Wolfgang Fraunhofer, Annika Bartl, Hans-Juergen Krause, Markus Tschoepe, Katharina Kaleta
Assignee: AbbVie Biotechnology Ltd
Application Number:US17/137,246

Details for Patent 11,191,834

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. HUMIRA adalimumab Injection 125057 December 31, 2002 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 February 21, 2008 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 April 24, 2013 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 September 23, 2014 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 November 23, 2015 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 March 09, 2016 11,191,834 2040-12-29
Abbvie Inc. HUMIRA adalimumab Injection 125057 October 17, 2016 11,191,834 2040-12-29
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 11,191,834

Country Patent Number Estimated Expiration
South Africa 201205433 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2014130064 ⤷  Get Started Free
World Intellectual Property Organization (WIPO) 2009073569 ⤷  Get Started Free
United States of America 9085619 ⤷  Get Started Free
United States of America 8883146 ⤷  Get Started Free
United States of America 8420081 ⤷  Get Started Free
United States of America 2023007847 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.